Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

TORNTPHARM.NS


Top 10 Correlated ETFs

TORNTPHARM.NS


Top 10 Correlated Stocks

TORNTPHARM.NS


Financial details

Company Rating
Strong Buy
Market Cap
513.15B
Income
8.01B
Revenue
85.91B
Book val./share
163.43
Cash/share
32.41
Dividend
40
Dividend %
2.58%
Employees
12.7K
Optionable
No
Shortable
Yes
Earnings
-
P/E
65.57
Forward P/E
14.56
PEG
-18.18
P/S
6.11
P/B
8.82
P/C
48.13
P/FCF
53.33
Quick Ratio
0.17
Current Ratio
1.17
Debt / Equity
0.66
LT Debt / Equity
0.36
-
-
EPS (TTM)
23.65
EPS next Y
107.14
EPS next Q
102.66
EPS this Y
-37.93%
EPS next Y
353.1%
EPS next 5Y
580.17%
EPS last 5Y
2.76%
Revenue last 5Y
7.53%
Revenue Q/Q
8.94%
EPS Q/Q
-399%
-
-
-
-
SMA20
-0.85%
SMA50
2.08%
SMA100
13.56%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
14%
ROC
0.21%
Gross Margin
71%
Oper. Margin
21%
Profit Margin
9%
Payout
169%
Shs Outstand
338.44M
Shs Float
96.92M
-
-
-
-
Target Price
-
52W Range
1242.075-1649.25
52W High
-5.41%
52W Low
+25.59%
RSI
58
Rel Volume
1.59
Avg Volume
275.21K
Volume
436.69K
Perf Week
3.96%
Perf Month
-0.07%
Perf Quarter
13.34%
Perf Half Y
11.03%
-
-
-
-
Beta
0.28504
-
-
Volatility
20.57%, 20.85%
Prev Close
0.91%
Price
1559.85
Change
3.4%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-03-31

Metric History 2018-03-312019-03-312020-03-312021-03-31 2022-03-31
Revenue per share
173.06220.47229.87233.01248.76
Net income per share
20.0412.8930.2836.9922.96
Operating cash flow per share
26.4253.1341.1259.4253.27
Free cash flow per share
3.0433.5429.149.5247.27
Cash per share
40.1734.4919.5721.8122.31
Book value per share
136.57139.59142.51172.47175.89
Tangible book value per share
-30.7-10.653.1944.6763.47
Share holders equity per share
136.57139.59142.51172.47175.89
Interest debt per share
199.95193.21185.8154.54127.79
Market cap
240.04B303.23B396.89B424.62B476.25B
Enterprise value
302.25B357.72B448.68B467.64B512.97B
P/E ratio
35.469.538.7333.9261.29
Price to sales ratio
4.14.065.15.385.66
POCF ratio
26.8416.8628.5221.1126.41
PFCF ratio
233.2126.7140.2925.3429.77
P/B Ratio
5.196.428.237.278
PTB ratio
5.196.428.237.278
EV to sales
5.164.795.775.936.09
Enterprise value over EBITDA
18.3821.2919.618.4123.94
EV to operating cash flow
33.819.8932.2423.2528.45
EV to free cash flow
293.6531.5145.5527.932.06
Earnings yield
0.030.010.030.030.02
Free cash flow yield
00.040.020.040.03
Debt to equity
0.890.830.680.510.36
Debt to assets
0.680.670.660.590.55
Net debt to EBITDA
3.783.242.261.691.71
Current ratio
1.010.980.911.131.17
Interest coverage
3.092.733.395.136.94
Income quality
1.324.121.361.612.32
Dividend Yield
0.010.010.020.010.01
Payout ratio
0.390.710.70.270.87
Sales general and administrative to revenue
0.10.080.080.070
Research and developement to revenue
000.0100
Intangibles to total assets
0.40.360.340.310.29
Capex to operating cash flow
-0.88-0.37-0.29-0.17-0.11
Capex to revenue
-0.14-0.09-0.05-0.04-0.02
Capex to depreciation
-1.94-1.07-0.62-0.51-0.31
Stock based compensation to revenue
00000
Graham number
248.13201.21311.58378.87301.43
ROIC
0.10.150.180.20.2
Return on tangible assets
0.080.050.110.130.08
Graham Net
-215.04-214.56-220.96-181.98-152.49
Working capital
601.5M-1.28B-4.73B6.3B7.5B
Tangible asset value
-10.39B-3.6B1.08B15.12B21.48B
Net current asset value
-43.58B-43.59B-42.06B-27.16B-19.82B
Invested capital
1.41.281.210.840.68
Average receivables
00000
Average payables
20.58B20.82B20.72B20.67B18.7B
Average inventory
23.24B23.08B24.15B26.81B25.72B
Days sales outstanding
00000
Days payables outstanding
420.76329.64336.54337.49250.11
Days of inventory on hand
403.92304.23348.1437.81367.84
Receivables turnover
00000
Payables turnover
0.871.111.081.081.46
Inventory turnover
0.91.21.050.830.99
ROE
0.150.090.210.210.13
Capex per share
-23.38-19.58-12.02-9.9-6

Quarterly Fundamentals Overview

Last date of statement is 2020-09-30 for Q2

Metric History 2018-09-302019-03-312019-09-302020-03-31 2020-09-30
Revenue per share
112.0753.83118.9956.558.65
Net income per share
10.59-4.4814.489.279.16
Operating cash flow per share
48.2813.2842.4910.2810.28
Free cash flow per share
38.828.3933.657.287.28
Cash per share
57.3434.4934.7819.5732.41
Book value per share
280.18139.6301.05142.52163.43
Tangible book value per share
564.44-10.65538.253.1929.9
Share holders equity per share
280.18139.6301.05142.52163.43
Interest debt per share
329.59181.96248.83175.5119.49
Market cap
279.27B321.5B280.97B333.66B473.79B
Enterprise value
326.54B375.99B318.2B385.44B508.64B
P/E ratio
156.02-52.98115.1526.5938.21
Price to sales ratio
14.7517.6514.0117.4523.87
POCF ratio
34.2271.5239.2495.89136.17
PFCF ratio
42.57113.2849.55135.49192.4
P/B Ratio
5.96.815.546.928.57
PTB ratio
5.96.815.546.928.57
EV to sales
17.2420.6415.8720.1625.62
Enterprise value over EBITDA
85.71302.8563.2669.3879.53
EV to operating cash flow
40.0283.6444.44110.77146.18
EV to free cash flow
49.78132.4856.12156.52206.55
Earnings yield
0.0100.010.010.01
Free cash flow yield
0.020.010.020.010.01
Debt to equity
2.180.831.750.680.66
Debt to assets
0.690.670.640.660.62
Net debt to EBITDA
12.4143.897.49.325.45
Current ratio
0.980.981.090.911.17
Interest coverage
-1.632.63-2.553.855.11
Income quality
4.56-2.962.931.111.12
Dividend Yield
0000.010
Payout ratio
0.47-0.510.280.570.58
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.370.360.350.340.31
Capex to operating cash flow
-5.1-0.37-4.81-0.29-0.29
Capex to revenue
-11.84-0.09-13.46-0.05-0.05
Capex to depreciation
-1.89-1.07-2.17-0.62-0.62
Stock based compensation to revenue
00000
Graham number
258.4118.66313.18172.41183.53
ROIC
0.020.040.030.040.05
Return on tangible assets
0.02-0.020.030.030.03
Graham Net
-377.01-214.57-334.08-220.97-194.24
Working capital
-1.47B-1.28B4.3B-4.73B8.41B
Tangible asset value
-7.77B-3.6B1.67B1.08B10.12B
Net current asset value
-45.43B-43.59B-38.68B-42.06B-32.23B
Invested capital
01.2801.210.71
Average receivables
16.16B015.87B00
Average payables
21.6B19.4B20.2B19.3B20.47B
Average inventory
20.91B22.74B20.54B23.8B25.77B
Days sales outstanding
75.08068.3200
Days payables outstanding
368.54296.86328.38304.66375.11
Days of inventory on hand
333.89273.98327.88315.13412.8
Receivables turnover
1.201.3200
Payables turnover
0.240.30.270.30.24
Inventory turnover
0.270.330.270.290.22
ROE
0.04-0.030.050.070.06
Capex per share
-9.47-4.9-8.84-3-3

Frequently Asked Questions

What is Torrent Pharmaceuticals Limited stock symbol ?

Torrent Pharmaceuticals Limited is a IN stock , located in Ahmedabad of Gujarat and trading under the symbol TORNTPHARM.NS

What is Torrent Pharmaceuticals Limited stock quote today ?

Torrent Pharmaceuticals Limited stock price is $1559.85 today.

Is Torrent Pharmaceuticals Limited stock public?

Yes, Torrent Pharmaceuticals Limited is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks